“It’s always nice to get money in the bank.”
That’s what Gandeeva Therapeutics’ founder and CEO Sriram Subramaniam said, after revealing that his company landed $40 million in Series A funding. Gandeeva will use the money for its artificial intelligence-enabled platform to identify small molecules and biologics at a faster...
